Aview LCS
AI-powered identification and assessment of pulmonary nodules for chest LDCT.
Overview
Aview LCS helps clinicians with the review, analysis and reporting of thoracic CT images to characterize lung nodules in a single study, or over the course of several thoracic studies.

Features
- Nodule localization within the right upper lobe (RUL), right middle lobe (RML), right lower lobe (RLL), left upper lobe (LUL), and left lower lobe (LLL).
- Clearly marks the position of each nodule, aiding in accurate diagnosis and follow-up.
- Provides quantification on nodule size - effective diameter, volume, minimum and maximum Hounsfield Units (HU).
- Automatic calculation of volume doubling time (VDT) on follow-up.
- Evaluating nodules in accordance with Brock score, LungRADS and the European Union Position Statement on Lung Cancer Screening guidelines.
- Generates detailed and summarized reports on the findings, including nodule characteristics, measurements, and risk assessments.



Benefits
Aview LCS aims to :
- Reduce radiologist workload, allowing them to focus on critical diagnoses.
- Enhance the efficiency and accuracy of lung nodule detection and reporting.
- Improve the standardization and implementation of lung cancer screening.
Image examples
To find out more about this solution or any of the other 140+ applications on the Blackford Platform, please book a discovery call with our team.

Book a meeting
We’d welcome the opportunity to learn more about your AI needs and to explain how partnering with Blackford can drive efficiency and provide ongoing value.
Book a Meeting